Evidence to approve of Biogen’s Alzheimer’s drug was not ‘sufficient,’ says Penn’s Dr. Jason Karlawi

Subscribe to The Global Herald in Google News

CNBC Television published this video item, entitled “Evidence to approve of Biogen’s Alzheimer’s drug was not ‘sufficient,’ says Penn’s Dr. Jason Karlawi” – below is their description.

Dr. Jason Karlawish, co-director of the University of Pennsylvania Medical Center, joins ‘The News with Shepard Smith’ to discuss the new Alzheimer’s drug, saying that the evidence to approve the drug “was not sufficient.”

CNBC Television YouTube Channel

Got a comment? Leave your thoughts in the comments section, below. Please note comments are moderated before publication.


Subscribe to The Global Herald in Google News

About This Source - CNBC Television

CNBC is an American pay television business news channel, which primarily carries business day coverage of U.S. and international financial markets. Following the end of the business day and on non-trading days, CNBC primarily carries financial and business-themed documentaries and reality shows.

As of February 2015, CNBC is available to approximately 93,623,000 pay television households (80.4% of households with television) in the United States.

Recent from CNBC Television:

  • Wedbush’s Joel Kulina breaks down Netflix, Tesla reports
  • Netflix shares down after initial boost from earnings
  • Is Google’s new Pixel 6 smartphone an iPhone killer?
  • Leave a Comment

    We don't require your email address now, just your name. BUT, if you do add it, you may be notified if there are replies to your comment. Please make respectful comments, which add value, and avoid personal attacks on others. Comments failing to adhere to these guidelines will not be published.

    Posting....